Insulet Corporation

PODD

$200.35

Name : Insulet Corporation

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $14,103,809,024.00

EPSttm : 3.48

Insulet Corporation

$200.35

1.32%

$2.60

PODD — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.35

Margin Of Safety %

Put/Call OI Ratio

0.9

EPS Next Q Diff

-0.11

EPS Last/This Y

2.83

EPS This/Next Y

1.74

Price

197.85

Target Price

338.78

Analyst Recom

1.48

Performance Q

-31.56

Upside

-38.1%

Beta

1.41

Ticker: PODD

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	PODD	230.55	0.75	0.14	6897
2026-03-18	PODD	230.18	0.73	0.03	7027
2026-03-19	PODD	228.64	0.73	2.00	7053
2026-03-20	PODD	227.09	0.73	0.19	7046
2026-03-23	PODD	227	0.93	0.44	5498
2026-03-24	PODD	225.56	0.93	0.24	5532
2026-03-25	PODD	215	0.92	6.40	5524
2026-03-26	PODD	218.1	0.93	0.70	5544
2026-03-27	PODD	208.18	0.92	0.66	5577
2026-03-30	PODD	208.12	0.92	2.28	5660
2026-03-31	PODD	209.28	0.93	0.08	5720
2026-04-01	PODD	206.99	0.89	0.47	5829
2026-04-02	PODD	204.03	0.88	1.44	5928
2026-04-06	PODD	203.47	0.88	6.00	5931
2026-04-08	PODD	203.57	0.89	0.64	6001
2026-04-09	PODD	199.39	0.89	11.80	6022
2026-04-13	PODD	197.75	0.90	0.41	6071
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	PODD	230.54	17.8	153.3	6.35
2026-03-18	PODD	230.25	17.8	138.8	6.35
2026-03-19	PODD	228.57	17.8	96.4	6.35
2026-03-20	PODD	227.10	17.8	96.8	6.35
2026-03-23	PODD	227.07	17.8	100.0	6.35
2026-03-24	PODD	225.60	17.8	97.1	6.35
2026-03-25	PODD	215.98	17.8	79.3	6.35
2026-03-26	PODD	218.17	17.8	105.0	6.35
2026-03-27	PODD	208.17	17.8	77.7	6.35
2026-03-30	PODD	208.04	17.2	99.6	6.35
2026-03-31	PODD	209.88	17.2	104.5	6.35
2026-04-01	PODD	207.00	17.2	93.5	6.35
2026-04-02	PODD	204.28	17.2	93.7	6.35
2026-04-06	PODD	203.49	17.2	98.0	6.35
2026-04-07	PODD	202.53	17.2	97.6	6.35
2026-04-09	PODD	199.42	17.2	98.1	6.35
2026-04-10	PODD	196.95	17.2	2.3	6.35
2026-04-13	PODD	197.85	17.1	9.0	6.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	PODD	1.75	1.49	4.02
2026-03-18	PODD	1.75	1.49	4.02
2026-03-19	PODD	1.75	1.49	4.02
2026-03-20	PODD	1.75	1.49	4.02
2026-03-23	PODD	1.75	1.48	4.02
2026-03-24	PODD	1.75	1.48	4.02
2026-03-25	PODD	1.75	1.48	3.65
2026-03-26	PODD	1.75	1.48	3.65
2026-03-27	PODD	1.75	1.48	3.65
2026-03-30	PODD	1.75	1.50	3.65
2026-03-31	PODD	1.75	1.50	3.65
2026-04-01	PODD	1.75	1.50	3.65
2026-04-02	PODD	1.75	1.50	3.65
2026-04-06	PODD	1.75	1.53	3.65
2026-04-07	PODD	1.75	1.53	3.65
2026-04-08	PODD	1.75	1.53	3.65
2026-04-09	PODD	1.75	1.53	3.65
2026-04-10	PODD	1.75	1.53	3.65
2026-04-13	PODD	1.75	1.59	4.35
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.55

Avg. EPS Est. Current Quarter

1.2

Avg. EPS Est. Next Quarter

1.44

Insider Transactions

1.75

Institutional Transactions

1.59

Beta

1.41

Average Sales Estimate Current Quarter

729

Average Sales Estimate Next Quarter

789

Fair Value

207.59

Quality Score

Growth Score

100

Sentiment Score

Actual DrawDown %

44.3

Max Drawdown 5-Year %

-61.3

Target Price

338.78

P/E

56.51

Forward P/E

24.43

PEG

0.9

P/S

5.14

P/B

9.19

P/Free Cash Flow

36.87

EPS

3.5

Average EPS Est. Cur. Y

6.34

EPS Next Y. (Est.)

8.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.12

Relative Volume

0.64

Return on Equity vs Sector %

-11

Return on Equity vs Industry %

4.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PODD Healthcare

$197.81

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

13/25

Volume

9/15

Valuation

18/20

TP/AR

2/10

Options

2/10

RSI

24.8

Range 1M

7.4%

Sup Dist

1.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

22/30

Estimates

6/20

Inst/Vol

3/15

Options

4/10

EPS Yr

27.4%

EPS NY

27.8%

52W%

1.8%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +37.2% upside

Quality

16/30

Valuation

13/30

Growth

18/25

Stability

7/10

LT Trend

3/5

Upside

+37.2%

Quality

MoS

Insulet Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 5400

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

PODD

Latest News

—

Caricamento notizie per PODD…

stock quote shares PODD – Insulet Corporation Stock Price stock today

news today PODD – Insulet Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch PODD – Insulet Corporation yahoo finance google finance

stock history PODD – Insulet Corporation invest stock market

stock prices PODD premarket after hours

ticker PODD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PODD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y